Skip to content

Effects Of Gong's Versus Mulligan Mobilization In Patients With Adhesive Capsulitis

Effects Of Gong's Versus Mulligan Mobilization On Pain, Range Of Motion, Functional Disability and Quality Of Life In Patients With Adhesive Capsulitis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06686277
Enrollment
60
Registered
2024-11-13
Start date
2024-04-24
Completion date
2025-02-24
Last updated
2024-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Capsulitis of Shoulder

Keywords

Adhesive capsulitis, Functional Disability, Range of Motion

Brief summary

A Randomized Clinical Trial will be conducted at DHQ hospital kasur,BIT hospital kasur,Arif memorial hospital Lahore.Pre-diagnosed patients will be reassessed by applying (Shoulder Shrug Sign, Hand to neck, Hand to scapula, Hand to opposite scapula,Hand to back,Capsular pattern movement restriction)Plus all other special tests will be applied to confirm that symptoms are not due to other shoulder pathologies but are due to just adhesive capsulitis then through consecutive sampling technique on 60 patients they will be allocated using computer generated sampling(random number table) into Group A and Group B.

Detailed description

A Randomized Clinical Trial will be conducted at DHQ hospital kasur,BIT hospital kasur,Arif memorial hospital Lahore.Pre-diagnosed patients will be reassessed by applying (Shoulder Shrug Sign, Hand to neck, Hand to scapula, Hand to opposite scapula,Hand to back,Capsular pattern movement restriction)Plus all other special tests will be applied to confirm that symptoms are not due to other shoulder pathologies but are due to just adhesive capsulitis then through consecutive sampling technique on 60 patients they will be allocated using computer generated sampling(random number table) into Group A and Group B. Group A will be treated with Gong's mobilization and Group B will be treated with Mulligan MWM The procedures will be performed Three sets of 10 repetitions, with 1 minute rest between sets,thrice per week for a total of six weeks. Pre and post intervention values will be taken on 1st day and after 6 weeks. Outcome measures will be conducted through VAS for pain,SPADI for functional disability , goniometer for range of motion ,SF-36 for quality of life after 6 weeks. Data will be analyzed during SPSS software version 25. After assessing normality of data by Shapiro-wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups.

Interventions

Mulligan Mobilization Technique

OTHERGong's Mobilization Technique

The therapist will push the scapula of the affected side in a posterior to anterior direction with one hand, and pushed the humeral head in an anterior to posterior direction parallel to joint plane with the other hand.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Assessor blinded

Intervention model description

Randomized Clinical Trial

Eligibility

Sex/Gender
ALL
Age
40 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age 40 to 50 years * Both male and female * Pre-diagnosed Unilateral Primary Frozen shoulder patients * Prediagnosed Stage 3(Frozen phase) patients(27)

Exclusion criteria

* Patients with previous surgery in the shoulder joint * History of recent fracture or severe trauma to the shoulder * Diagnosed instability or previous history of dislocation * Systemic inflammatory conditions(e.g.rheumatoid arthritis)

Design outcomes

Primary

MeasureTime frameDescription
Level of PainPre & Post 6 weeksNumeric Pain Rating Scale
Range of MotionPre & Post 6 weeksGoniometer
Functional DisabilityPre & Post 6 weeksShoulder Pain and Disability Index
Quality of Life LevelPre & Post 6 weeksSort Form Survey-36

Countries

Pakistan

Contacts

Primary ContactImran Amjad, Phd PT
imran.amjad@riphah.edu.pk03324390125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026